NASDAQ
Bellerophon Therapeutics, Inc. (BLPH) has a free cash flow growth of -28.67% as of Friday, May 29, 2026. This represents a 15.93% decrease compared to its 12-month average of -24.73%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.